Gentris has signed a strategic partnering agreement with Bluechiip Limited, an Australian company that has developed a unique temperature sensing and tracking solution for cryogenic sample management in the healthcare and life science industry. As a member of the Bluechiip Early Adopter Program, Gentris plans to utilize the bluechiip® solution in its Integrated Biorepository. The bluechiip® system will allow the temperature of individual samples to be measured and tracked over time. Ultimately, this information can be used to determine how changes in temperature over the life of a sample affect sample integrity and will help interpret the results from downstream testing.
For more information, please follow the link below.